HK1129841A1 - Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine - Google Patents

Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine

Info

Publication number
HK1129841A1
HK1129841A1 HK09107703.4A HK09107703A HK1129841A1 HK 1129841 A1 HK1129841 A1 HK 1129841A1 HK 09107703 A HK09107703 A HK 09107703A HK 1129841 A1 HK1129841 A1 HK 1129841A1
Authority
HK
Hong Kong
Prior art keywords
gen
cholest
carbon
image
cytoprotective
Prior art date
Application number
HK09107703.4A
Other languages
English (en)
Inventor
Rebecca Pruss
Bruno Buisson
Thierry Bordet
Original Assignee
Trophos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos filed Critical Trophos
Publication of HK1129841A1 publication Critical patent/HK1129841A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK09107703.4A 2006-03-31 2009-08-21 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine HK1129841A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602799A FR2899108B1 (fr) 2006-03-31 2006-03-31 Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur
PCT/FR2007/000530 WO2007118967A1 (fr) 2006-03-31 2007-03-28 Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur

Publications (1)

Publication Number Publication Date
HK1129841A1 true HK1129841A1 (en) 2009-12-11

Family

ID=36954506

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09107703.4A HK1129841A1 (en) 2006-03-31 2009-08-21 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine

Country Status (18)

Country Link
US (1) US9320745B2 (ja)
EP (1) EP2001483B1 (ja)
JP (2) JP5662020B2 (ja)
KR (1) KR101409027B1 (ja)
CN (1) CN101443019B (ja)
AT (1) ATE493989T1 (ja)
AU (1) AU2007239395B2 (ja)
BR (1) BRPI0709925A8 (ja)
CA (1) CA2647501C (ja)
DE (1) DE602007011739D1 (ja)
DK (1) DK2001483T3 (ja)
ES (1) ES2359173T3 (ja)
FR (1) FR2899108B1 (ja)
HK (1) HK1129841A1 (ja)
IL (1) IL194293A0 (ja)
MX (1) MX2008012611A (ja)
RU (1) RU2428189C2 (ja)
WO (1) WO2007118967A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
FR2919180B1 (fr) * 2007-07-25 2009-11-27 Trophos Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
JP2011502112A (ja) * 2007-10-30 2011-01-20 トロフォ 抗ガン治療の副作用を治療するための新規組成物
WO2012069150A2 (en) 2010-11-22 2012-05-31 Powerpore Gmbh Cytoprotectant agents for the prevention of drug-associated side-effects
FR2979239A1 (fr) 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol
TWI637951B (zh) 2013-02-15 2018-10-11 英商葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之雜環醯胺類
RU2629772C1 (ru) * 2016-05-31 2017-09-04 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Кардиопротекторная фармацевтическая субстанция и способ ее получения
CN107746423B (zh) * 2017-09-07 2020-02-14 佛山科学技术学院 麦角甾-7，22-二烯-3-酮肟及其制备方法和在制备抗菌药物中的应用
CN115040524A (zh) * 2022-07-27 2022-09-13 深圳市中西医结合医院 4-胆甾烯-3-酮用于治疗多发性骨髓瘤骨病的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3186365B2 (ja) * 1993-09-02 2001-07-11 日本油脂株式会社 肝疾患治療薬
JP3129367B2 (ja) * 1993-10-08 2001-01-29 日本油脂株式会社 角化亢進抑制剤
PL1601363T3 (pl) * 2003-03-11 2012-11-30 Trophos Zastosowanie pochodnych cholest-4-en-onu jako leków, kompozycje farmaceutyczne zawierające te pochodne, nowe pochodne i sposób ich wytwarzania
EP1618881A1 (en) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Use of non-glucocorticoid steroids for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
DK2001483T3 (da) 2011-04-18
US9320745B2 (en) 2016-04-26
AU2007239395B2 (en) 2012-05-24
JP2009531397A (ja) 2009-09-03
RU2428189C2 (ru) 2011-09-10
CN101443019B (zh) 2013-07-17
ES2359173T3 (es) 2011-05-19
KR101409027B1 (ko) 2014-06-18
WO2007118967A1 (fr) 2007-10-25
JP5662020B2 (ja) 2015-01-28
FR2899108B1 (fr) 2012-02-03
MX2008012611A (es) 2008-10-31
FR2899108A1 (fr) 2007-10-05
EP2001483B1 (fr) 2011-01-05
RU2008143248A (ru) 2010-05-10
AU2007239395A1 (en) 2007-10-25
CA2647501C (fr) 2013-10-08
CN101443019A (zh) 2009-05-27
IL194293A0 (en) 2009-09-22
CA2647501A1 (fr) 2007-10-25
US20090186863A1 (en) 2009-07-23
DE602007011739D1 (de) 2011-02-17
BRPI0709925A2 (pt) 2011-08-02
JP2014051525A (ja) 2014-03-20
EP2001483A1 (fr) 2008-12-17
KR20090016549A (ko) 2009-02-16
BRPI0709925A8 (pt) 2018-04-24
ATE493989T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
HK1129841A1 (en) Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
NO20052167L (no) Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe
WO2002044192A1 (fr) Derives de glucopyranosyloxybenzylbenzene, compositions medicinales contenant ces derives et produits intermediaires obtenus lors de l'elaboration de ces compositions
MX2012012952A (es) Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina.
MX2010007375A (es) Nuevos derivados de lupano.
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
EP1400529A4 (en) GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
TW200745070A (en) Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and their use
ATE435202T1 (de) Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung
WO2008020027A3 (en) 2,5-dihydroxybenzene compounds for the treatment of skin cancer
WO2009082818A8 (en) Novel c-21-keto lupane derivatives preparation and use thereof
AU2006299184A8 (en) Novel nitrocatechol derivatives having selectin ligand activity
NZ612717A (en) Treatment of pain associated with dislocation of basal endometrium
WO2011025982A3 (en) Tetracycline compounds
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
NZ602445A (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
WO2008096769A1 (ja) 置換されたセルコスポラミド誘導体を含有する医薬
WO2010129057A3 (en) Tetracycline compounds
WO2007010294A8 (en) Use of delmopinol in the treatment of acne
UY27959A1 (es) Nuevos agonistas ppar alfa y ppar gama
BR0209735A (pt) Derivados heterocìclicos e uso medicinal destes
WO2009016081A3 (en) Benzoind0l-2-one derivatives for use in therapy
HK1101065A1 (ja)
PA8525101A1 (es) Nuevos derivados de aminociclohexanol
WO2002009717A1 (fr) Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200331